Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI

Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI

PurposeThe study evaluated the diagnostic performance of the Liver Imaging Reporting and Data System (LI-RADS) version 2018 for differentiating hepatocellular carcinoma (HCC) from primary liver cancer in patients with liver cirrhosis based on the updated 2019 WHO classification.Materials and Methods...

Full description

Bibliographic Details
Main Authors:	Xinai Liu, Xiaoyan Ni, Yubo Li, Chun Yang, Yi Wang, Chunzheng Ma, Changwu Zhou, Xin Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma (HCC) primary liver cancer (PLC) cirrhosis LI-RADS combined hepatocellular-cholangiocarcinoma (cHCC-CC) intrahepatic cholangiocarcinoma (ICC)
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.934045/full

Similar Items

Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)
by: Marcus Bahra, et al.
Published: (2023-01-01)

Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma
by: Alexander A. Azizi, et al.
Published: (2020-09-01)

Therapy of Primary Liver Cancer
by: Mei Feng, et al.
Published: (2020-08-01)

Pediatric combined hepatocellular-cholangiocarcinoma (cHCC-CC) with neuroendocrine features: distinguishing genetic alterations detected by chromosomal microarray
by: Alyeesha B. Wilhelm, et al.
Published: (2023-02-01)

Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends
by: Jiakun Wang, et al.
Published: (2019-02-01)

Development and validation of nomogram to predict very early recurrence of combined hepatocellular-cholangiocarcinoma after hepatic resection: a multi-institutional study
by: Yijun Wu, et al.
Published: (2022-02-01)

Ataxia-telangiectasia and combined hepatocellular-cholangiocarcinoma: A case report
by: Tej P Singh, et al.
Published: (2023-01-01)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
by: Ming-Chun Ma, et al.
Published: (2018-02-01)

Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma
by: Nan Zhou, et al.
Published: (2023-10-01)

Prognostic significance of three‐tiered pathological classification for microvascular invasion in patients with combined hepatocellular‐cholangiocarcinoma following hepatic resection
by: Yijun Wu, et al.
Published: (2023-03-01)

Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma
by: Jemmy Zhao, et al.
Published: (2023-02-01)

Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
by: Florian Roßner, et al.
Published: (2023-01-01)

Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
by: Takamichi Ishii, et al.
Published: (2020-12-01)

Consensus Report From the Miami Liver Proton Therapy Conference
by: Michael D. Chuong, et al.
Published: (2019-05-01)

Hippo Signaling in the Liver – A Long and Ever-Expanding Story
by: Saumya Manmadhan, et al.
Published: (2019-03-01)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
by: Peipei Song, et al.
Published: (2019-10-01)

Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
by: Lang Chen, et al.
Published: (2020-02-01)

Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch databaseResearch in context
by: Weiqi Liao, et al.
Published: (2023-05-01)

Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma—Own Experiences and Review of the Literature
by: Laura Schwenk, et al.
Published: (2023-07-01)

The Diagnostic Role of Arginase-1, MOC-31, and CDX2 in the Differentiation of Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colonic Carcinoma of the Liver
by: Hanaa Atwa, et al.
Published: (2019-10-01)

Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics
by: Ning Liu, et al.
Published: (2023-11-01)

Editorial: The predictive benefits of inflammatory markers in cancers of the liver
by: Gianluca Rompianesi, et al.
Published: (2024-03-01)

Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
by: Kun Cheng, et al.
Published: (2022-11-01)

A Multi-Parametric Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion Status in Intrahepatic Cholangiocarcinoma
by: Xianling Qian, et al.
Published: (2022-02-01)

Radiogenomics and Radiomics in Liver Cancers
by: Aman Saini, et al.
Published: (2018-12-01)

Identification of the origin of tumor in vein: comparison between CEUS LI-RADS v2017 and v2016 for patients at high risk
by: Wen-juan Tong, et al.
Published: (2022-10-01)

Clinical and DCE-CT signs in predicting microvascular invasion in cHCC-ICC
by: Zhong-Jian Liao, et al.
Published: (2023-11-01)

Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2022-06-01)

Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany
by: Smita George Thoduka, et al.
Published: (2023-12-01)

Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies
by: Jonathan Charles, et al.
Published: (2023-05-01)

Clinical Value of Machine Learning-Based Ultrasomics in Preoperative Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Multicenter Study
by: Shanshan Ren, et al.
Published: (2021-11-01)

PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1
by: Fuqiang Huang, et al.
Published: (2024-03-01)

Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience
by: Daniel Aliseda, et al.
Published: (2023-01-01)

Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma
by: Zhuanbo Yang, et al.
Published: (2024-03-01)

A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case
by: Qiang Fu, et al.
Published: (2022-03-01)

Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function
by: Jingnan Wang, et al.
Published: (2021-05-01)

Recent Trends and In-Hospital Mortality of Transarterial Chemoembolization (TACE) in Germany: A Systematic Analysis of Hospital Discharge Data between 2010 and 2019
by: Sarah Krieg, et al.
Published: (2022-04-01)

Percutaneous Radio-frequency Assisted Liver Partition with Portal vein embolization in Staged liver resection (PRALPPS) in patients with perihilar and intrahepatic cholangiocarcinoma: evaluation of short-term results
by: O. V. Melekhina, et al.
Published: (2019-04-01)

Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center
by: Lea Penzkofer, et al.
Published: (2023-01-01)

Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the QResearch® database: research protocol and statistical analysis plan
by: Weiqi Liao, et al.
Published: (2022-10-01)